ELI LILLY & Co is 648.4x more valuable than Zymeworks Inc. by market capitalization ($1.093 T vs $1.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ZYME | LLY |
|---|---|---|
| Market cap | $1.69 B | $1.093 T |
| US-listed rank | #2236 | #11 |
| Revenue (latest FY) | $105.97M | $65.18B |
| Net income (latest FY) | -$81.13M | $20.64B |
| Net margin | -76.6% | 31.7% |
| P/E (trailing FY) | - | 53.0 |
| SEC filings | 324 | 989 |
ELI LILLY & Co is 648.4x more valuable than Zymeworks Inc. by market capitalization ($1.093 T vs $1.69 B).
In their latest fiscal years, Zymeworks Inc. reported $105.97M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Zymeworks Inc. and ELI LILLY & Co, or browse the full rankings.